NEW YORK (GenomeWeb News) - Rosetta Genomics said today that its CEO, Amir Avniel, has moved his office from the company's headquarters in Rehovot, Israel, to New York as part of a plan to expand its US operations.
The company said the move will "facilitate the expected launch of Rosetta Genomics' first products, growth through partnerships and collaborations, as well as corporate operations in the US."
"As we move closer to the planned launch of our first diagnostic products in 2008 and to ensure the growth and expansion of our technologies, it is critical to have our senior executives based in the US," said Yoav Chelouche, Rosetta Genomics' chairman of the board of directors.
Michael French, president of the company’s US subsidiary, Rosetta Genomics Inc., has departed the company. Avniel will assume French's responsibilities, the company said.